# Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

> **NCT01709474** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 7 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Vitamin D3 6000 IU
- **DRUG:** Vitamin D3 400 IU

## Key facts

- **NCT ID:** NCT01709474
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Due to slow enrollment
- **Last updated:** 2015-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709474, "Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01709474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*